BRCA2 and ovarian cancer: Notably, these observations are independent of both the BRCA2 status of the ovarian cancer cells (BRCA2 wildtype or BRCA2 mutant) and the G4 mapping technique used (BG4 ChIP-Seq or BG4 CUT&Tag).